for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Novavax Says Initiates Efficacy Trial Of COVID-19 Vaccine In South Africa

Aug 17 (Reuters) - Novavax Inc:

* NOVAVAX INITIATES EFFICACY TRIAL OF COVID-19 VACCINE IN SOUTH AFRICA

* BILL & MELINDA GATES FOUNDATION PROVIDING $15 MILLION GRANT TOWARD TRIAL

* BEGINNING OF A PHASE 2B CLINICAL TRIAL IN SOUTH AFRICA TO EVALUATE EFFICACY OF NVX-COV2373, NOVAVAX’ COVID-19 VACCINE CANDIDATE Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up